Search clinical trials for: Poly-Adp Ribose Polymerase (Parp)-1 Inhibitor
Total 103605 results
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProstate CancerUnited States
-
Jeil Pharmaceutical Co., Ltd.Completed
-
AbbVie (prior sponsor, Abbott)Completed
-
Paul Mathew, MDHoosier Cancer Research Network; Tesaro, Inc.TerminatedMetastatic Prostate CancerUnited States
-
Tesaro, Inc.Merck Sharp & Dohme LLCCompletedNeoplasms | Breast Cancer | Advanced Breast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Peritoneal Cancer | Stage IV Breast CancerUnited States
-
Jun GuoNot yet recruiting
-
National Cancer Institute (NCI)RecruitingPancreatic Acinar Cell CarcinomaUnited States
-
PfizerMedivation, Inc.CompletedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationKorea, Republic of, United States, Australia, Spain, Belgium, France, Ireland, Taiwan, Poland, Germany, Israel, Brazil, United Kingdom, Italy, Russian Federation, Ukraine
-
PfizerMedivation, Inc.; Myriad Genetic Laboratories, Inc.TerminatedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationUnited States, Spain, United Kingdom, Germany, France
-
Zin W MyintMerck Sharp & Dohme LLCRecruiting
-
Sohag UniversityRecruiting
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLCRecruitingAdvanced Gastric AdenocarcinomaUnited States
-
zr Pharma & GmbHBristol-Myers Squibb; Foundation MedicineTerminatedFallopian Tube Cancer | Epithelial Ovarian Cancer | Endometrioid Adenocarcinoma | High Grade Serous Carcinoma | Primary Peritoneal CarcinomaUnited States
-
Qilu Hospital of Shandong UniversityJiangsu HengRui Medicine Co., Ltd.Not yet recruitingSmall Cell Lung Cancer
-
PfizerActive, not recruitingNeoplasms | Breast NeoplasmsJapan
-
SanofiCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AstraZeneca; The Marcus Foundation; McGuff Pharmaceuticals, Inc.RecruitingProstate Cancer | Castration-resistant Prostate CancerUnited States
-
University Hospital, CaenCompleted
-
Xiaoxiang ChenNot yet recruitingOvarian Cancer | HRD | PARP InhibitorChina
-
University of Michigan Rogel Cancer CenterDana-Farber Cancer Institute; Vanderbilt University Medical CenterActive, not recruitingBiliary Tract CancerUnited States
-
Fudan UniversityRecruitingTreatment EfficacyChina
-
Teva Branded Pharmaceutical Products R&D, Inc.Terminated
-
University of Michigan Rogel Cancer CenterPfizer; Acrotech Biopharma Inc.RecruitingMetastatic Breast Cancer | Metastatic Castration-resistant Prostate Cancer | Metastatic Ovarian CarcinomaUnited States
-
First Affiliated Hospital of Harbin Medical UniversityNot yet recruitingSmall-cell Lung Cancer
-
Washington University School of MedicineActive, not recruiting
-
University Hospital, CaenCompleted
-
Allarity TherapeuticsDanish Breast Cancer Cooperative Group; Smerud Medical Research International...Active, not recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
Centre Georges Francois LeclercActive, not recruiting
-
AstraZenecaCompletedOvarian Neoplasms | BRCA1 Protein | BRCA2 ProteinNetherlands, Belgium, United Kingdom, Poland
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Jennifer Lauren KamensGateway for Cancer ResearchRecruitingAcute Myeloid LeukemiaUnited States
-
Centre Francois BaclesseNational Cancer Institute, FranceRecruitingRadiotherapy | PARP Inhibitor | Malignant GliomasFrance
-
California Pacific Medical Center Research InstituteM.D. Anderson Cancer CenterRecruitingMetastatic MelanomaUnited States
-
University of Alabama at BirminghamWithdrawnOvarian Cancer RecurrentUnited States
-
University of Texas Southwestern Medical CenterWithdrawn
-
Hoosier Cancer Research NetworkClovis Oncology, Inc.CompletedBreast CancerUnited States
-
Inotek Pharmaceuticals CorporationCompletedAcute Myocardial InfarctionUnited States, Israel
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid NeoplasmUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisMerck Sharp & Dohme LLCNot yet recruiting
-
Erasmus Medical CenterRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide TherapyNetherlands
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Breast Carcinoma | Ovarian Carcinoma | Pancreatic Carcinoma | Prostate Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative... and other conditionsUnited States
-
Tango Therapeutics, Inc.RecruitingBreast Cancer | Ovarian Cancer | Prostate Cancer | Pancreas Cancer | BRCA1 Mutation | BRCA-Mutated Ovarian Carcinoma | BRCA-Associated Breast Carcinoma | HRD Positive Advanced Ovarian CancerUnited States
-
Abramson Cancer Center at Penn MedicineActive, not recruiting
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Ovarian Epithelial TumorUnited States
-
Zai Lab (Shanghai) Co., Ltd.Completed
-
AbbVie (prior sponsor, Abbott)CompletedBrain Diseases | Central Nervous System Diseases | Neoplasm Metastasis | Brain Neoplasms | Nervous System NeoplasmsUnited States, Canada, Puerto Rico
-
Fudan UniversityRecruitingNasopharyngeal Carcinoma | Nasopharyngeal CancerChina
-
Ronald BuckanovichGenentech, Inc.RecruitingPARP Inhibitor | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Hedgehog InhibitorUnited States